PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 12.21pm 23/04/2024 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | 3.2¢ | Day High | 3.4¢ | Day Low | 3.2¢ | |||
Daily Volume | 3886881 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
3 | 3.1¢ | 199516 | 1 | 3.2¢ | 228 |
Directors & Senior Management
Mr. Scott Burkhart | Chief Executive Officer |
Mr. Peter Zardo | Chief Operating Officer, Managing Director, Director |
Mr. Alister Morrison | Chief Development Officer |
Mr. Neville John Bassett | Company Secretary |
Ms. Sylvia Medlyn Tulloch | Non-Executive Chairman of the Board |
Mr. Robert Hartley Downey | Non-Executive Director |
Data source: Refinitiv